Meningioma other diagnostic studies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Haytham Allaham, M.D. [3]
Overview
Overview
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index is suggestive of a rapid growth rate of meningioma and a greater incidence of recurrence following surgical resection.
Other Diagnostic Studies
Other Diagnostic Studies
Bromodeoxyuridine Labeling Study
Bromodeoxyuridine labeling study may be helpful in the diagnosis of meningioma. An elevated bromodeoxyuridine labeling index of meningioma is associated with:[1]
- Rapid growth rate of the tumor
- Greater incidence of recurrence following surgical resection of the tumor
References
References
- ↑ Lee KS, Hoshino T, Rodriguez LA, Bederson J, Davis RL, Wilson CB (1990). “Bromodeoxyuridine labeling study of intracranial meningiomas: proliferative potential and recurrence”. Acta Neuropathol. 80 (3): 311–7. PMID 2399811.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH